FDA recall D-1702-2019
RXQ Compounding LLC · Class II · drug
Product
ROPIVICAINE 0.2%, INJ SOLN, 550 ML ON-Q PUMP. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0238-55
Reason for recall
Lack of Assurance of Sterility
Distribution
Nationwide USA
Key facts
- Status
- Terminated
- Initiation date
- 2019-06-19
- Report date
- 2019-08-14
- Termination date
- 2022-09-16
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Athens, OH, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1702-2019